Psoriatic Arthritis, Juvenile (DBCOND0155645)

Identifiers

Synonyms

Juvenile psoriatic arthritis / Oligoarthritis, Juvenile / Juvenile psoriatic arthritis (disorder)

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Secukinumab	An immunomodulating agent and interleukin antagonist used to manage plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders.	Interleukin-17Atarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05754710	Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis	Tofacitinib	Not Available	Not Available	active_not_recruiting
NCT03769168	An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)	Secukinumab	treatment	3	active_not_recruiting
NCT05767047	A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis	Apremilast	treatment	3	recruiting
NCT06100744	A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab	Adalimumab Isopropyl alcohol Risankizumab	treatment	3	recruiting
NCT05252533	A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis	Ustekinumab	other	1	completed
NCT05545839	Transition to Adulthood Through Coaching and Empowerment in Rheumatology	No drug interventions	supportive_care	Not Available	recruiting
NCT03031782	Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)	Secukinumab	treatment	3	completed
NCT04527380	A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis	Adalimumab Ixekizumab	treatment	3	active_not_recruiting